citric acid, anhydrous has been researched along with DDD MPGNII in 1 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romick-Rosendale, LE | 1 |
| Brunner, HI | 1 |
| Bennett, MR | 1 |
| Mina, R | 1 |
| Nelson, S | 1 |
| Petri, M | 1 |
| Kiani, A | 1 |
| Devarajan, P | 1 |
| Kennedy, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proteomics Combined With Metabolomics Studies on the Efficacy of Telitacicept in Chinese Patients of Systemic Lupus Erythematosus[NCT05666336] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for citric acid, anhydrous and DDD MPGNII
| Article | Year |
|---|---|
Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Topics: Citric Acid; Diagnosis, Differential; Female; Glomerulonephritis, Membranoproliferative; Glomerulone | 2011 |